Anonymous
Guest
Anonymous
Guest
Pharma sales is a funny thing. Of course we want to help patients but we are measured on sales. We execute a marketing plan that has hints of patient benifits. But in the case of VPak it's not a real patient game changer. Yea it's a cure with bagage. Harvoni is cure with less bagage. Docs and patients like less bagage. Fact.! When new meds come out before us we will beoved down the food chain. There is not an HCV expert who says differently. On a good note I have interviews lined up. Time for a change. Best of luck.
Good luck my NYC friend!